NovoTTF-200A

DEVICE7 trials

Conditions

Astrocytoma, Grade IIIBrain MetastasesGlioblastomaGlioblastoma MultiformeGlioblastoma, AdultGliomaMelanoma Brain MetastasisMetastatic Melanoma

Early Phase 1

Study of NovoTTF-200A Alone and With Temozolomide in Patients With Low-Grade Gliomas

TerminatedNCT02507232

Santosh KesariGlioma

Start: 2017-04-17End: 2020-07-27Updated: 2020-07-28

Phase 1

NovoTTF-200A and Temozolomide Chemoradiation for Newly Diagnosed Glioblastoma

CompletedNCT03232424

Hackensack Meridian HealthGlioblastoma, Adult

Start: 2017-07-26End: 2022-12-07Updated: 2024-11-18

NovoTTF-200A + Pembrolizumab In Melanoma Brain Metastasis

WithdrawnNCT04129515

Brown UniversityMelanoma Brain Metastasis, Metastatic Melanoma

Start: 2025-10-30End: 2026-01-31Updated: 2026-01-02

Unknown Phase

Study Of NOVOTTF-200A In Bevacizumab-Naive Subjects With Recurrent Grade III Malignant Astrocytoma

CompletedNCT03450850

Daniela A. BotaAstrocytoma, Grade III

Start: 2020-05-21End: 2025-08-07Updated: 2026-02-17

Radiosurgery Plus NovoTTF-200A for Metastatic Small Cell Lung Cancer to the Brain

TerminatedNCT03488472

Drexell Hunter BoggsBrain Metastases, Small Cell Lung Cancer

Start: 2019-08-09End: 2022-02-15Updated: 2023-05-06

TTFields Together With Temozolomide and Radiotherapy in Patients With Newly Diagnosed GBM

NCT03780569

NovoCure Ltd.Glioblastoma Multiforme

Start: 2017-04-27End: 2019-01-31Target: 10Updated: 2018-12-20

NovoTTF-200A Together With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed GBM

NCT03869242

Tel-Aviv Sourasky Medical CenterGlioblastoma

Start: 2018-10-01End: 2021-12-01Target: 60Updated: 2019-03-11

Related Papers

RTID-12. PHASE 2 TRIAL OF TUMOR TREATING FIELDS (TTFIELDS) PLUS RADIATION THERAPY (RT) PLUS TEMOZOLAMIDE (TMZ) COMPARED TO RT PLUS TEMOZOLOMIDE IN NEWLY DIAGNOSED GLIOBLASTOMA (ndGBM)

Neuro-Oncology2020-11-011 citations

Abstract CT206: Concurrent Tumor Treating Fields (TTFields) and radiation therapy for newly diagnosed glioblastoma: A safety and feasibility study

Cancer Research2020-08-151 citations

Updated safety/feasibility study of concurrent tumor treating fields (TTFields) and radiation therapy for newly diagnosed glioblastoma.

Journal of Clinical Oncology2020-05-20

ACTR-62. A PHASE II STUDY OF TUMOR TREATING FIELDS (TTFIELDS) WITH TEMOZOLOMIDE IN PATIENTS WITH LOW-GRADE GLIOMAS

Neuro-Oncology2017-11-011 citations